{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:18:25Z","timestamp":1756995505355},"reference-count":0,"publisher":"Canadian Science Publishing","issue":"9","license":[{"start":{"date-parts":[[1971,9,1]],"date-time":"1971-09-01T00:00:00Z","timestamp":52531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.nrcresearchpress.com\/page\/about\/CorporateTextAndDataMining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Physiol. Pharmacol."],"published-print":{"date-parts":[[1971,9,1]]},"abstract":"<jats:p> In rats, spironolactone and ethylestrenol, like phenobarbital, enhance the NADPH-dependent hydroxylation of benzo(a)pyrene in the hepatic microsomal plus supernatant fraction and increase liver weight and microsomal phospholipid content as well as NADPH cytochrome c reductase and diaphorase activities, but only ethylestrenol and phenobarbital influence the microsomal protein content and cytochrome P-450 level.Neither spironolactone, ethylestrenol, nor phenobarbital affects NADH cytochrome c reductase and diaphorase activities, and only phenobarbital alters the cytochrome b<jats:sub>5<\/jats:sub> level.These findings indicate that, while both the steroids and phenobarbital stimulate microsomal mixed-function oxidation, there are qualitative and quantitative differences between their action. <\/jats:p>","DOI":"10.1139\/y71-115","type":"journal-article","created":{"date-parts":[[2011,4,23]],"date-time":"2011-04-23T16:40:58Z","timestamp":1303576858000},"page":"841-846","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Spironolactone and Ethylestrenol on Benzo(<i>a<\/i>)pyrene Hydroxylase (EC 1.14.1.1) and Other Chemical Constituents of Hepatic Microsomes"],"prefix":"10.1139","volume":"49","author":[{"given":"B.","family":"Solymoss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Werringloer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zsigmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"155","container-title":["Canadian Journal of Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nrcresearchpress.com\/doi\/pdf\/10.1139\/y71-115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T11:16:33Z","timestamp":1578222993000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nrcresearchpress.com\/doi\/10.1139\/y71-115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,9,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1971,9,1]]}},"alternative-id":["10.1139\/y71-115"],"URL":"https:\/\/doi.org\/10.1139\/y71-115","relation":{},"ISSN":["0008-4212","1205-7541"],"issn-type":[{"value":"0008-4212","type":"print"},{"value":"1205-7541","type":"electronic"}],"subject":[],"published":{"date-parts":[[1971,9,1]]}}}